TABLE 1 .
Strain | Origin | Source |
---|---|---|
Lab “wild-type” strains | ||
AF293 | Lung biopsy specimen of neutropenic IPA patient | David Denning Laboratory |
CEA10 (CBS144.89) | Patient with IPA | CBS-KNAW Fungal Biodiversity Centre |
Environmental isolates | ||
47-4 (AF250, FA210) | Salford Hope Hospital, Manchester, UK | Paul Dyer, Nottingham, UK |
47-10 (AF221) | Sawmill wood, New Zealand | Paul Dyer, Nottingham, UK |
47–57 (AFIR957) | Air sample, Dublin, Ireland | Paul Dyer, Nottingham, UK |
W72310 | Sputum | Memorial Sloan Kettering, NY, USA |
47-7 (AF217) | Sawmill, Sweden | Paul Dyer, Nottingham, UK |
47-9 (AF70) | Air sample, NJ, USA | Paul Dyer, Nottingham, UK |
47-60 (AFRB3) | Air samples, Dublin, Ireland | Paul Dyer, Nottingham, UK |
08-19-02-10 (02-10) | Netherlands, Nijmegen | Darius Armstrong, Imperial College London, London, UKa |
08-19-02-30 (02-30) | Netherlands, Berghem | Darius Armstrong, Imperial College London, London, UKa |
8-19-02-46 (02-46) | Netherlands, Nijmegen | Darius Armstrong, Imperial College London, London, UKa |
Clinical isolates | ||
M35662 | Lung biopsy specimenb | Memorial Sloan Kettering, NY, USA |
F78107 | Lung biopsy specimenb | Memorial Sloan Kettering, NY, USA |
F30186 | Bronchial wash | Memorial Sloan Kettering, NY, USA |
W73763 | Bronchial wash | Memorial Sloan Kettering, NY, USA |
See reference 75 for information on this Netherlands strain.
These are proven invasive aspergillosis based on modified EORTC criteria.